A Duchenne Muscular Dystrophy Drug Gains Patient Support by ANDREW POLLACK

By ANDREW POLLACK

The staff of the Food and Drug Administration said a clinical trial for the drug, eteplirsen, was too small, but advocates said the drug prolonged patients’ ability to walk.

Published: April 26, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1MTQ32Q

from WordPress http://ift.tt/1VOKaax
via Hadi Aboukhater